Public procurement notice: Contract Award Notice
Published: 2017-12-06
Buyer: "Victor Babeș" University of Medicine and Pharmacy Timișoara
Country: RO
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33169100
Estimated value: 855420.17 EUR
Award criteria: Lowest price

Technical requirements: Lot_1: Refractive surgery platform (Laser Excimer, Femtosecond laser, Topographic/ tomography Diagnosis of the refraction unit);
The Refractive surgery platform is a surgical and diagnostic equipment intended for advanced corneal laser treatments.
The Refractive surgery platform should include the Excimer laser (1 piece), the Femtosecond laser (1 piece) and the Topography/Tomography/Aberrometry Diagnosis Refractive Unit (1 piece).
The femtosecond laser is cutting the cornea and is used to produce different kinds of very specialized cuts into the cornea in order to provide corneal flaps for FemtoLasik, intracorneal channels for intracorneal rings, antiastigmic relaxing incisions, intracorneal pockets for corneal inlays, grafts for lamellar and penetrating keratoplasties and/or other possible procedures.
The excimer laser is sculpting the cornea and is used to produce different kinds of corneal shaping patterns in order to treat myopia, hyperopia, astigmatism and even presbyopia by aspherical, aberration-free, topography-guided and/or wavefront-guided corneal stromal ablations.
The topography/tomography/aberrometry Diagnosis Refractive Unit is a diagnostic tool which comprehensively evaluates the corneal profile in order to properly select the patients which could be treated with corneal lasers (femtosecond and excimer lasers) and to precisely plan the laser cornea refractive surgery according to the particularities of each patient's cornea. This diagnosis system is providing detailed maps of the anterior and posterior surface of the cornea, of the cornea thickness, of the optical aberration of the cornea (corneal wavefront maps) or the entire eye (ocular wavefront maps).
The refractive laser surgery platform is evaluating and treating the patients with different kinds of corneal diseases like refractive errors (myopia, hyperopia, astigmatism), corneal ectasias, and corneal opacities by shaping and reshaping the corneal tissue according to several treatment patterns and strategies.
The Refractive Surgery Platform is a surgical and diagnostic equipment intended for advanced corneal laser treatments which include the Excimer laser, the Femtosecond laser and the Topography/Tomography/Aberrometry Diagnosis Refractive Unit.
1. All the contained items should be able to work with the same software, mainly the excimer laser and the diagnosis refractive unit, in order to be able to provide customised wave-front ablations (corneal and ocular) for our patients. If they will be acquired as independent units each of them will have its own software which is not compatible with other equipment and we’ll be able just to analyze the patients, but not to individualize the treatments by customized surgery. Having all these elements together in one big item should include the guarantee of the supplier that they can work together sharing information in order to offer a fluent surgery for our patients.
2. The femtosecond laser and the excimer laser should share the same operating table which should be integrated with the software for surgery in order to adapt the patient position to the specificity of the surgery. If they will be acquired as independent units each of them will have its own operating table which means that we’ll need to mobilize the patients from one item to the other during the surgery, which is interfering with the quality of the surgery and the patient’s comfort.
1. The tender guarantee is set at Lot 01 - Refractive surgery platform = 16 000.00 EUR, and must be presented in the form specified in the Annex to the tender dossier. It must remain valid for 45 days beyond the period of validity of the tender.
2. The successful tenderer will be required to provide a performance guarantee of 10 % of the amount of the contract at the signing of the contract.
The micropulse 577 mm laser system is a surgical equipment intended for advanced retinal treatments.The device is used to produce a therapeutic treatment without inducing intraretinal damage detectable on clinical examination during or after treatment. The controlled laser delivery of micropulse technology affords treatment options for diabetic macular edema (DME), proliferative diabetic retinopathy (PDR), central serous chorioretinopathy (CSR), macular edema secondary to branch retinal vein occlusion (BRVO), and even glaucoma.
1. The tender guarantee is set at Lot 02 - Micropulse laser = 1 000.00 EUR, and must be presented in the form specified in the Annex to the tender dossier. It must remain valid for 45 days beyond the period of validity of the tender.
2. The successful tenderer will be required to provide a performance guarantee of 10 % of the amount of the contract at the signing of the contract.


Winner: ROMGER GENERAL TRADE & CONSULTING SRL
Award value: 855420.17
Number of bids: 3